3Pirker R,Pereira JR,Szezesna A,et al. Cetuximabplusehe- motherapy in patients withadvaneed non - small - eel/ lungeaneer (FLEX) : an open - label randomizedphase l]I trial [ J ]. Lancet, 2009,373 (9674) : 1525.
4GordonM S, Margo lin K, TalpazM, et al. Phase I safety and pharmaeokinetie study of reeombinanthuman anti - vascular endothelia 1 growth factor inpatients with advaneedeaneer[ J]. Cli- nOneo,12001,19(4) :843.
5Freeman D J, Bush T, Ogbagabriel S, et al. Activity of pani- tumumabalone or with chemotherapy in non -small celllung carci- noma cell lines expressing mutant epidermal growth factor receptor [ J]. Mol Cancer Ther,2009,8(6) :1536.
6Socinski MA. Antibodies to the Epidermal Growth Factor- Receptor in Non -Small Cell Lung Cancer: Current Status of Matuzumab and Panitumumab [ J ]. Clin Cancer Res,2007,13 ( 15 Pt2): s4597.
7Spicer J, Harper P. Targeted therapies for non - small cell lung cancer[J]. In t J C 1 in Pract,2005.59(9) :1055.
